Profile data is unavailable for this security.
About the company
bioXXmed AG, formerly CytoTools AG, is a Germany-based holding company that invests in biotechnological or medical technology companies with equity or borrowed capital. The Company holds interests in research and development (R&D) companies DermaTools Biotech GmbH, which is active in the field of dermatology and urology, and CytoPharma GmbH, which is engaged in product development for cardiovascular diseases, cancer and other indications. bioXXmed AG manages the patent portfolio and coordinates the licensing for its subsidiaries. The product pipeline of disease modifying therapies based on the mechanisms of cell growth and programmed cell death, comprising small molecules and biologics across a range of disease indications, includes DermaPro, the Company's lead product indicated for diabetic and venous foot ulcers in phase III of clinical trials, as well as Utisept, an urological medical device for flushing the bladder in urinary tract infections.
- Revenue in EUR (TTM)17.40k
- Net income in EUR-20.95m
- Incorporated2006
- Employees1.00
- LocationbioXXmed AGRiedstrasse 2DARMSTADT 64295GermanyDEU
- Phone+49 61 519515812
- Fax+49 61 519515813
- Websitehttps://bioxxmed.ag/